Literature DB >> 17636018

ASB4 is a hydroxylation substrate of FIH and promotes vascular differentiation via an oxygen-dependent mechanism.

James E Ferguson1, Yaxu Wu, Kevin Smith, Peter Charles, Kyle Powers, Hong Wang, Cam Patterson.   

Abstract

The molecular mechanisms of endothelial differentiation into a functional vascular network are incompletely understood. To identify novel factors in endothelial development, we used a microarray screen with differentiating embryonic stem (ES) cells that identified the gene for ankyrin repeat and SOCS box protein 4 (ASB4) as the most highly differentially expressed gene in the vascular lineage during early differentiation. Like other SOCS box-containing proteins, ASB4 is the substrate recognition molecule of an elongin B/elongin C/cullin/Roc ubiquitin ligase complex that mediates the ubiquitination and degradation of substrate protein(s). High levels of ASB4 expression in the embryonic vasculature coincide with drastic increases in oxygen tension as placental blood flow is initiated. However, as vessels mature and oxygen levels stabilize, ASB4 expression is quickly downregulated, suggesting that ASB4 may function to modulate an endothelium-specific response to increasing oxygen tension. Consistent with the hypothesis that ASB4 function is regulated by oxygen concentration, ASB4 interacts with the factor inhibiting HIF1alpha (FIH) and is a substrate for FIH-mediated hydroxylation via an oxygen-dependent mechanism. Additionally, overexpression of ASB4 in ES cells promotes differentiation into the vascular lineage in an oxygen-dependent manner. We postulate that hydroxylation of ASB4 in normoxia promotes binding to and degradation of substrate protein(s) to modulate vascular differentiation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17636018      PMCID: PMC2099627          DOI: 10.1128/MCB.00511-07

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  47 in total

1.  Gene expression profile signatures indicate a role for Wnt signaling in endothelial commitment from embryonic stem cells.

Authors:  Hong Wang; Peter C Charles; Yaxu Wu; Rongqin Ren; Xinchun Pi; Martin Moser; Michal Barshishat-Kupper; Jeffrey S Rubin; Charles Perou; Victoria Bautch; Cam Patterson
Journal:  Circ Res       Date:  2006-04-06       Impact factor: 17.367

2.  Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch.

Authors:  David Lando; Daniel J Peet; Dean A Whelan; Jeffrey J Gorman; Murray L Whitelaw
Journal:  Science       Date:  2002-02-01       Impact factor: 47.728

3.  Itch/AIP4 mediates Deltex degradation through the formation of K29-linked polyubiquitin chains.

Authors:  Patricia Chastagner; Alain Israël; Christel Brou
Journal:  EMBO Rep       Date:  2006-10-06       Impact factor: 8.807

4.  Multiple factors affecting cellular redox status and energy metabolism modulate hypoxia-inducible factor prolyl hydroxylase activity in vivo and in vitro.

Authors:  Yi Pan; Kyle D Mansfield; Cara C Bertozzi; Viktoriya Rudenko; Denise A Chan; Amato J Giaccia; M Celeste Simon
Journal:  Mol Cell Biol       Date:  2006-11-13       Impact factor: 4.272

5.  Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages.

Authors:  Steven J Kattman; Tara L Huber; Gordon M Keller
Journal:  Dev Cell       Date:  2006-11       Impact factor: 12.270

6.  Mind bomb is a ubiquitin ligase that is essential for efficient activation of Notch signaling by Delta.

Authors:  Motoyuki Itoh; Cheol-Hee Kim; Gregory Palardy; Takaya Oda; Yun-Jin Jiang; Donovan Maust; Sang-Yeob Yeo; Kevin Lorick; Gavin J Wright; Linda Ariza-McNaughton; Allan M Weissman; Julian Lewis; Settara C Chandrasekharappa; Ajay B Chitnis
Journal:  Dev Cell       Date:  2003-01       Impact factor: 12.270

7.  Structure of factor-inhibiting hypoxia-inducible factor (HIF) reveals mechanism of oxidative modification of HIF-1 alpha.

Authors:  Jonathan M Elkins; Kirsty S Hewitson; Luke A McNeill; Jurgen F Seibel; Imre Schlemminger; Christopher W Pugh; Peter J Ratcliffe; Christopher J Schofield
Journal:  J Biol Chem       Date:  2002-11-21       Impact factor: 5.157

Review 8.  The SOCS box: a tale of destruction and degradation.

Authors:  Benjamin T Kile; Brenda A Schulman; Warren S Alexander; Nicos A Nicola; Helene M E Martin; Douglas J Hilton
Journal:  Trends Biochem Sci       Date:  2002-05       Impact factor: 13.807

Review 9.  The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis.

Authors:  Christopher William Pugh; Peter John Ratcliffe
Journal:  Semin Cancer Biol       Date:  2003-02       Impact factor: 15.707

10.  Posttranslational hydroxylation of ankyrin repeats in IkappaB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH).

Authors:  Matthew E Cockman; David E Lancaster; Ineke P Stolze; Kirsty S Hewitson; Michael A McDonough; Mathew L Coleman; Charlotte H Coles; Xiaohong Yu; Ronald T Hay; Steven C Ley; Christopher W Pugh; Neil J Oldham; Norma Masson; Christopher J Schofield; Peter J Ratcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-26       Impact factor: 11.205

View more
  42 in total

1.  Factor inhibiting HIF (FIH) recognizes distinct molecular features within hypoxia-inducible factor-α (HIF-α) versus ankyrin repeat substrates.

Authors:  Sarah E Wilkins; Sarah Karttunen; Rachel J Hampton-Smith; Iain Murchland; Anne Chapman-Smith; Daniel J Peet
Journal:  J Biol Chem       Date:  2012-01-23       Impact factor: 5.157

Review 2.  Sent to destroy: the ubiquitin proteasome system regulates cell signaling and protein quality control in cardiovascular development and disease.

Authors:  Monte S Willis; W H Davin Townley-Tilson; Eunice Y Kang; Jonathon W Homeister; Cam Patterson
Journal:  Circ Res       Date:  2010-02-19       Impact factor: 17.367

3.  Prevention of apoptosis by the interaction between FIH1 and Bax.

Authors:  Biao Yan; Men Kong; Yi-han Chen
Journal:  Mol Cell Biochem       Date:  2010-11-11       Impact factor: 3.396

4.  The effect of human embryonic stem cells (hESCs) long-term normoxic and hypoxic cultures on the maintenance of pluripotency.

Authors:  Vladimir Zachar; Sinha M Prasad; Simon C Weli; Anette Gabrielsen; Karsten Petersen; Michael B Petersen; Trine Fink
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-02-23       Impact factor: 2.416

Review 5.  New Insights into Protein Hydroxylation and Its Important Role in Human Diseases.

Authors:  Giada Zurlo; Jianping Guo; Mamoru Takada; Wenyi Wei; Qing Zhang
Journal:  Biochim Biophys Acta       Date:  2016-09-20

6.  Continuous hypoxic culturing maintains activation of Notch and allows long-term propagation of human embryonic stem cells without spontaneous differentiation.

Authors:  S M Prasad; M Czepiel; C Cetinkaya; K Smigielska; S C Weli; H Lysdahl; A Gabrielsen; K Petersen; N Ehlers; T Fink; S L Minger; V Zachar
Journal:  Cell Prolif       Date:  2009-02       Impact factor: 6.831

7.  ASB9 interacts with ubiquitous mitochondrial creatine kinase and inhibits mitochondrial function.

Authors:  Sanghoon Kwon; Dongbum Kim; Jae Won Rhee; Jeong-A Park; Dae-Won Kim; Doo-Sik Kim; Younghee Lee; Hyung-Joo Kwon
Journal:  BMC Biol       Date:  2010-03-19       Impact factor: 7.431

8.  Hypoxia-dependent sequestration of an oxygen sensor by a widespread structural motif can shape the hypoxic response--a predictive kinetic model.

Authors:  Bernhard Schmierer; Béla Novák; Christopher J Schofield
Journal:  BMC Syst Biol       Date:  2010-10-18

Review 9.  Hypoxia. The role of hypoxia and HIF-dependent signalling events in rheumatoid arthritis.

Authors:  Barbara Muz; Moddasar N Khan; Serafim Kiriakidis; Ewa M Paleolog
Journal:  Arthritis Res Ther       Date:  2009-01-20       Impact factor: 5.156

10.  Proteomics-based identification of novel factor inhibiting hypoxia-inducible factor (FIH) substrates indicates widespread asparaginyl hydroxylation of ankyrin repeat domain-containing proteins.

Authors:  Matthew E Cockman; James D Webb; Holger B Kramer; Benedikt M Kessler; Peter J Ratcliffe
Journal:  Mol Cell Proteomics       Date:  2008-10-20       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.